Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Search News Archive

Approvals Action
Novartis' newest drug
First-ever oral SPMS drug Mayzent arrives.
Pipeline Monitor
New Takeda, AbbVie results
Positive data on vaccine and arthritis drug.
Top of the Hill
Dear PBAC, love patient
Patients are talking but who is listening?